Company Filing History:
Years Active: 1997-2025
Title: James Andrew Jamison: Innovator in Pharmaceutical Science
Introduction
James Andrew Jamison is a prominent inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceutical science, particularly in the development of compounds for treating autoimmune and inflammatory diseases. With a total of 7 patents to his name, Jamison's work has had a substantial impact on medical research and treatment options.
Latest Patents
Among his latest patents, Jamison has developed glucocorticoid receptor agonists. These compounds are designed to be useful in the treatment of autoimmune and inflammatory diseases. The patent details processes for preparing these compounds and pharmaceutical compositions that include them. Additionally, he has worked on muscarinic agonists, which are compounds that act as agonists of the M-1 muscarinic receptor, showcasing his innovative approach to drug development.
Career Highlights
James Andrew Jamison is currently associated with Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to advancing healthcare. His work at Eli Lilly has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to pharmaceutical innovations.
Collaborations
Some of his notable coworkers include Michael J Rodriguez and William W Turner. Their collaborative efforts have likely played a role in the successful development of various pharmaceutical compounds.
Conclusion
James Andrew Jamison's innovative work in pharmaceutical science, particularly in the area of glucocorticoid receptor agonists and muscarinic agonists, highlights his significant contributions to medical research. His ongoing efforts at Eli Lilly and Company continue to pave the way for advancements in treatment options for autoimmune and inflammatory diseases.